Skip to content

Drug interactions

Amiodarone + Fosaprepitant

Severity: Moderate

Amiodarone and Fosaprepitant: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Fosaprepitant is converted to aprepitant, a moderate CYP3A4 inhibitor, which may increase amiodarone concentrations after a single dose. The effect is generally short-lived but could add to bradycardia or QT risk.

What this interaction means in plain words

Amiodarone and Fosaprepitant can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Amiodarone belongs to Cardiovascular; Fosaprepitant belongs to Gastrointestinal Tract.

Evidence level: Moderate

Why it happens

Aprepitant, the active metabolite, inhibits CYP3A4 and reduces amiodarone metabolism.

What to do

Monitor heart rate and ECG around the time of fosaprepitant administration, particularly with repeated chemotherapy cycles. Reduce amiodarone dose if toxicity develops.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Amiodarone and Fosaprepitant, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Amiodarone with Fosaprepitant?

MediHelp rates the interaction as moderate. Amiodarone and Fosaprepitant can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Fosaprepitant is converted to aprepitant, a moderate CYP3A4 inhibitor, which may increase amiodarone concentrations after a single dose. The effect is generally short-lived but could add to bradycardia or QT risk.

How serious is the interaction between Amiodarone and Fosaprepitant?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor heart rate and ECG around the time of fosaprepitant administration, particularly with repeated chemotherapy cycles. Reduce amiodarone dose if toxicity develops.

What other medicines interact with Amiodarone?

MediHelp also lists interactions of Amiodarone with, for example, Amisulpride, Arsenic trioxide, Dofetilide. The full list is on the Amiodarone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in